Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD

Hematologic

This is a multi-center study to evaluate the safety, tolerability, PK, PD, and clinical activity of EQ001 in subjects with Acute Graft Versus Host Disease (aGVHD).
Hematologic
I/II
Jagasia, Madan
NCT03763318
VICCBMT1911

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: